NCCAM Funding For Botanical/HIV Drug Interaction Research Set At $600,000
This article was originally published in The Tan Sheet
Executive Summary
Grant requests for Phase I/II clinical studies on botanicals' interaction with HIV drugs should "examine the pharmacokinetics or pharmacodynamics of the botanical/drug combination" compared to lone use of either product, the National Center for Complementary & Alternative Medicine says
You may also be interested in...
CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
Basic and clinical research on the potential benefits of CAM therapies for HIV/AIDS will be sponsored in 2003 by the National Center for Complementary & Alternative Medicine
Garlic Supplements, Protease Inhibitor Interactions Troublesome – NIH Study
A National Institutes of Health study finding garlic supplements reduce plasma concentration levels of an HIV protease inhibitor by approximately 50% could spur drug interaction warnings on such supplements
NCCAM Slowing Research Pace, Turning To Program Announcements
The National Center for Complementary & Alternative Medicine will issue proportionately more program announcements (PAs) in the coming year than requests for applications (RFAs), hedging against a possible upsurge of out-year costs for funded grants.